Strides Pharma Science Share Price

Strides Pharma

CMP as on 17-May-22 15:53

₹ 303.55
7.45 2.52%

Open

₹ 295.90

Turnover (lac)

₹ 1,791

Prev. Close

₹ 296.10

Day's Vol (shares)

₹ 5,90,070

Day's Range (₹)

₹ 291.00
₹ 304.50

CMP as on17-May-22 15:29

₹ 302.00
5.6 1.89%

Open

₹ 298.00

Turnover (lac)

₹ 141

Prev. Close

₹ 296.40

Day's Vol (shares)

₹ 42,436

Day's Range

₹ 291.05
₹ 304.50

CMP as on 17-May-22 15:29

₹ 302.95
6.9 2.33%

Open

₹ 296.75

Open Interest(Contracts)

₹ 40,91,400

VWAP

₹ 299.08

Day's Vol (shares)

₹ 6,11,100

Day's Range (Ex.Dt. 26 May 2022)

₹ 291.30
₹ 304.65

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 29-Mar-2022 - -
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Board Meeting - 21-Jan-2022 - -
Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2022 inter alia to consider and approve This is to inform you that meeting of Board of Directors of the Company is scheduled to be held on Friday January 28 2022 to consider and approve the un-audited financial results (standalone and consolidated) of the Company for the quarter and nine months ended December 31 2021 amongst other matters. Further as per the provisions of the Companys Code of Conduct for Prohibition of Insider Trading trading window for designated persons of the Company is closed and shall open after 48 hrs post declaration of financial results by the Company. This is for your kind information and record purposes. The Board Meeting to be held on 28/01/2022 has been revised to 10/02/2022 We refer to our letter dated January 21, 2022, regarding intimation of the date of Board Meeting of the Company scheduled to be held on January 28, 2022, inter alia, to consider and approve the un-audited financial results (standalone and consolidated) of the Company for the quarter and nine months ended December 31, 2021. Due to unavoidable circumstances, the said meeting has been rescheduled and will now be held on Thursday, February 10, 2022. As per the provisions of the Companys Code of Conduct for Prohibition of Insider Trading, trading window for designated persons of the Company is closed and shall open after 48 hrs post declaration of financial results by the Company. This is for your kind information and record purposes. (As per BSE Announcement Dated on 27/01/2022) We are pleased to enclose the Unaudited Financial Results (Standalone and Consolidated) of the Company along with Limited Review Report of the Statutory Auditors for the quarter and nine months ended December 31, 2021, as approved by the Board of Directors of the Company at their meeting held today, along with a press release issued in this regard. The board meeting commenced at 11:30 hrs and concluded at 13:10 hrs. This is for your information and record. Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) (As Per BSE Announcement Dated on 10/02/2022)
Board Meeting - 28-Jan-2022 - -
Allotment of shares under Strides ESOP 2016 Plan
Board Meeting - 03-Nov-2021 - -
Quarterly Results We are pleased to enclose the Unaudited Financial Results (Standalone and Consolidated) of the Company along with Limited Review Report of the Statutory Auditors for the quarter and half year ended September 30, 2021, as approved by the Board of Directors of the Company at their meeting held today, along with a press release issued in this regard. The board meeting commenced at 11:00 hrs and concluded at 13:30 hrs. This is for your information and record. (As Per BSE Announcement Dated on 10/11/2021)
Board Meeting - 29-Jul-2021 - -
Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2021 ,inter alia, to consider and approve This is to inform you that meeting of Board of Directors of the Company is scheduled to be held on Friday, August 6, 2021 to consider and approve the un-audited financial results (standalone and consolidated) of the Company for the quarter ended June 30, 2021, amongst other matters. Further, as per the provisions of the Companys Code of Conduct for Prohibition of Insider Trading, trading window for designated persons of the Company is closed from Thursday, July 1, 2021 upto Sunday, August 8, 2021 (both days inclusive). This is for your kind information and record purposes. We are pleased to enclose the Unaudited Financial Results (Standalone and Consolidated) of the Company along with Limited Review Report of the Statutory Auditors for the quarter ended June 30, 2021, as approved by the Board of Directors of the Company at their meeting held today, along with a press release issued in this regard. The board meeting commenced at 10:15 hrs and concluded at 12:20 hrs. This is for your information and record. The Board of Directors of the Company in their meeting held today have allotted 5,550 equity shares of face value of Rs. 10/- each to the eligible employees who have exercised their stock options under Strides ESOP 2016 Plan. These shares shall rank in pari passu with the existing equity shares of the Company in all respects. Consequent to above, the paid-up share capital of the Company has increased from Rs.89,71,71,640/- consisting of 8,97,17,164 equity shares of Rs. 10/- each to Rs.89,72,27,140/- consisting of 8,97,22,714 equity shares of Rs. 10/- each. (As Per BSE Announcement Dated on 06.08.2021)
Board Meeting - 20-May-2021 - -
Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2021 ,inter alia, to consider and approve This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Thursday, May 27, 2021 to consider and approve the audited financial results (standalone and consolidated) of the Company for the quarter and year ended March 31, 2021 and recommendation of dividend, if any, amongst other matters. Further, as per the provisions of the Companys Code of Conduct for Prohibition of Insider Trading, trading window for designated persons of the Company is closed from Thursday, April 1, 2021 upto Saturday, May 29, 2021 (both days inclusive). This is for your kind information and record purposes. The Board of Directors at their meeting held today i.e., on May 27, 2021, has inter-alia, approved the Audited Financial Statements (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2021. In this regard, please find enclosed the following: 1. A copy of the Audited Financial Statements (Standalone and Consolidated) for the quarter and year ended March 31, 2021 along with Auditors Report for the said period; 2. Declaration on Unmodified Opinion in the Auditors Report for Financial Year ended March 31, 2021; and 3. Press Release tilted Strides reports strong FY21 performance with 29% revenue and 67% EBITDA growth. The Board Meeting commenced at 11:45 hrs and concluded at 13:15 hrs. This is for your information and record. The Board of Directors at their meeting held today i.e., on May 27, 2021, have recommended final dividend of Rs. 2.50 /- per equity share of Rs. 10/- each for the financial year ended March 31, 2021. The dividend will be paid within 30 days from the date of shareholders approval at the ensuing Annual General Meeting of the Company. This is for your information and record. Allotment of shares under Strides ESOP 2016 Plan (As Per BSE Announcement dated on 27.05.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity